One MES to rule them all? LZ offers 'affordable' manufacturing software system

By Dan Stanton

- Last updated on GMT

Photograph -  Ahmetov_Ruslan/iStock
Photograph - Ahmetov_Ruslan/iStock

Related tags Manufacturing

Software firm LZ Lifescience says small drugmakers could increase their productivity by over 25% by accessing Manufacturing Execution Systems (MESs) traditionally restricted to Big Pharma firms

The replacement of paper-based processing administration systems with MES software can help increase efficiency by automating and managing a range of production processes, but according to LZ Lifescience the cost of such systems has restricted their use to the larger firms within the pharma industry.

“Smaller drug product or medical device makers have been excluded from using MES and have tended to scale their workforce to match production requirements, which means that increased production comes with increased overhead,”​ Christian Fortunel, who has just been hired to run the company’s US operations, told

“The platforms that have traditionally been deployed in ‘big pharma’ were designed for general industry and often continuous processes - including oil and gas, bulk chemicals - and not with life science processes in mind.”

He estimated that less than a third of approximately 75 MES vendors see more than 5% of their revenues come from the pharma industry, and these systems are not sector specific.

Therefore, the Dublin, Ireland-headquartered software firm has just launched an edition of its Shopfloor-Online MES to targeting the life science sector, which it says “significantly reduces the pricing barriers”​ which have until now kept small drugmakers from using such systems.

“Both large and small organisations can benefit and stay in the competitive race with this next generation, web technology based, simple, modular, and flexible system that already contains the building blocks and core functionality for life science manufacturing,”​ said Fortunel.

The software allows firms to simultaneously manage scheduling, production execution, workflow, quality and inventory, and could lead to dramatic increases in productivity, he continued.

“We calculate that it is possible to achieve gains of more than 25% in productivity, as well as reduce the time and stress associated with managing manufacturing using paper and hybrid systems.”

Related news

Related products

show more

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

Standardizing data with NCI controlled terminology

Standardizing data with NCI controlled terminology

Formedix | 13-Feb-2023 | Technical / White Paper

The use of consistent terminology within and between studies is critical to enabling an efficient trial process. CDISC standards such as CDASH, SDTM, SEND...

Related suppliers

Follow us


View more